Louise Frederika Kooij
Chief Accounting Officer · NewAmsterdam Pharma Co N.V.
- 2024
- Jul 22, 2026
- 12
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Louise Frederika Kooij files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Michael H. Davidson - $25.55M in NAMS purchases and sales in the last 12 months
- Johannes Jacob Pieter Kastelein - $15.52M in NAMS purchases and sales in the last 12 months
- Mayur Ian Somaiya - $3.43M in NAMS purchases and sales in the last 12 months
- Louis G. Lange - $2.19M in NAMS purchases and sales in the last 12 months
- John W. Smither - $41K in NAMS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Louise Frederika Kooij?
Louise Frederika Kooij is a corporate insider, tracked as Chief Accounting Officer of NewAmsterdam Pharma Co N.V. (NAMS). InsiderAlpha holds 12 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Louise Frederika Kooij submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has Louise Frederika Kooij been buying or selling stock?
Recorded transactions: 0 open-market purchases and 21 open-market sales ($21.99M) across all tracked filings.
